Rezultati

eNauka >  Results >  Combined use of 177Lu-DOTATATE peptide receptor radionuclide therapy and fluzoparib for treatment of well-differentiated neuroendocrine tumors: A preclinical study
Title: Combined use of <sup>177</sup>Lu-DOTATATE peptide receptor radionuclide therapy and fluzoparib for treatment of well-differentiated neuroendocrine tumors: A preclinical study
Authors: Fu J.; Qiu F.; Stolniceanu C.; Yu F.; Zang S.; Xiang Y.; Huang Y.; Matovic, Milovan ; Stefănescu C.; Tang Q.;
Wang F.;
Issue Date: 2022
Publication: Journal of Neuroendocrinology
ISSN: 0953-8194 Journal of Neuroendocrinology Search Idenfier
Type: Article
Collation: vol. 34 br. 4
DOI: 10.1111/jne.13109
WoS-ID: 000770558700001
Scopus-ID: 2-s2.0-85126440721
URI: https://scidar.kg.ac.rs/handle/123456789/15987
https://enauka.gov.rs/handle/123456789/590605
M-category: 
22M22

6
SCOPUSTM
1
OpenCitations
5
WEB OF SCIENCETM
Alt metrika
Dimensions
Unpaywall

Rezultati na eNauka su zaštićeni autorskim pravima i sva prava su zadržana, osim ako nije drugačije naznačeno.